Remove 2019 Remove Documentation Remove Specialty Pharmacies
article thumbnail

PBM-Owned Specialty Pharmacies Expand Their Role In—and Profits From—the 340B Program

Drug Channels

Last week, I documented that nearly half of U.S. pharmacies now participate in the 340B Drug Pricing Program. Below, we update our exclusive analysis of the biggest specialty pharmacies within 340B. As you will see below, these specialty pharmacies have dramatically increased their participation in the 340B program.

article thumbnail

Driving Provider Value for Specialty Pharmacies

National Association of Boards of Pharmacy

Launched in 2019, NABP’s Specialty Pharmacy Accreditation was created to accredit pharmacies providing advanced levels of pharmacy services and disease management tools for patients taking medications that require special handling, storage, and dispensing requirements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Overcome 340B ESP & Other Manufacturer Restrictions With Software And Human Insight

Proxsys Rx

Customized 340B software should be able to automatically document the journey of every eligible prescription written — from the providers to the retail and specialty contract pharmacies, and from billing to claiming-and-qualifying for 340B reimbursement. For an overview of Specialty Pharmacy Best Practices, Click Here.

article thumbnail

340B Outlook For 2024: Change. Change. And More Change.

Proxsys Rx

Between late 2019 and the end of 2023, ProxsysRx’s 340B Support program went from Zero to more than $500 million in savings generated for the hospitals and health systems we serve. Understand, and master, your 340B specialty pharmacy opportunities. The 340B revenue potential of specialty pharmacy is staggering.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Pharmacy benefit managers: transparency, accountability, and impact on patient care. Journal of Managed Care & Specialty Pharmacy, 27(7), 903-907.

article thumbnail

NHC Comments on Notice of Proposed Rulemaking on Discrimination on the Basis of Disability in Health and Human Service Programs or Activities

Putting Patients First Blog

A 2019 study highlighted that physicians’ biases could influence their clinical decision-making, which underscores the importance of awareness and training to mitigate such biases.15 15 The NHC advocates for rigorous, transparent documentation of the medical rationale in such instances to prevent discriminatory practices.